Moreover, the type of brain changes associated with Aβ, tau, and cerebrovascular disease are predictive of cognitive decline and of progression to mild cognitive impairment (MCI) and AD [18,19,20,21,22]. The gene discussed is MAPT; the disease is cerebrovascular disorder.